# Hexamer Therapeutics Inc.

Canonical: https://abierto.us/vendors/hexamer-therapeutics-inc-mk8hsfmvb647

- UEI: MK8HSFMVB647
- CAGE: 9CUB9
- Location: Pullman, WA
- Awards in window: 1 (4 transactions), $0 obligated, March 27, 2025 to June 3, 2026

## Awarding agencies

- Defense Health Agency: 1 awards, $0

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $0

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- HT942523C0078 (definitive contract): $0, Army Med Res Acq Activity. Peptide Based, Self-Assembling, Molecular Carrier (Scaffold) Vaccine Platform Ideal for Deployment During an Infectious Disease Pandemic by Offering Many Advantages.. https://www.usaspending.gov/award/CONT_AWD_HT942523C0078_9700_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/hexamer-therapeutics-inc-mk8hsfmvb647.